Evaluation of Hyperbaric Oxygen Combined with Drugs in the Treatment of Early Brain Nerve Injury

Abstract

Abstract: Objective To analyze the clinical effect of hyperbaric oxygen combined with pharmacotherapy in the early stage of cerebral nerve injury. Methods Fifty patients with brain nerve injury treated in the Hongqi Hospital Affiliated to Mudanjiang Medical College from February 2019 to January 2021 were selected as the research objects. They were randomly divided into the exploration group and the general group, with 25 cases in each group. The study group was treated with hyperbaric oxygen combined with nitroglycerin and aspirin enteric coated tablets, while the general group was treated with nitroglycerin and aspirin enteric coated tablets. The neurological deficit score, motor function score, swallowing function score, life ability score, neurological function improvement time, motor function improvement time, swallowing function improvement time and hospitalization time of the two groups were compared before and after treatment, and the treatment efficiency and the incidence of adverse reactions were calculated and compared. Results After treatment, compared to control group, the neural deficiency score of the investigation group was lower, whereas the movement function score, swallowing function score and living ability score were higher, which was significant in statistics(P<0.05). By comparison with control group, the improvement time of movement function, improvement time of swallowing function and hospital stay in investigation group were significantly much shorter, which was significant in statistics(P<0.05). The response rate of investigation group was higher than that of control group, while the incidence of side effects was lower, which was significant in statistics(P < 0.05). Conclusion The application of hyperbaric oxygen combined with pharmacotherapy in the treatment of cerebral nerve injury could shorten the time of symptoms, improve the deficiency of neural function, and enhance the movement function, swallowing function and living ability of patients.

Key words: hyperbaric oxygen, drugs, cerebral nerve injury, response rate

CLC Number:

R459.6

FU Wei, LIU Fei, HUANG Rui, ZHANG Xu-dong, LIANG Jun, YAN Lei, ZHANG Ping. Evaluation of Hyperbaric Oxygen Combined with Drugs in the Treatment of Early Brain Nerve Injury[J]. ZHONGHUA YANGSHENG BAOJIAN, 2022, 40(18): 8-11.

References

[1] 邓萍,张义.不同时间运用阿替普酶对脑梗死治疗后患者认知情况的影响分析[J].云南医药,2021,42(4):342-344.
[2] 陈明波. 丁苯酞联合阿替普酶溶栓治疗急性脑梗死的临床效果[J].临床合理用药杂志,2021,14(23):51-52.
[3] 张雄智,丁彦博,贾燕燕.阿加曲班联合依达拉奉对后循环急性脑梗死患者神经功能恢复及血清Hcy、CXCL16和TGF-β1的影响[J].中国动脉硬化杂志,2021,29(8):695-701.
[4] 王茂基. 丁苯酞联合法舒地尔治疗急性脑梗死的疗效观察[J].航空航天医学杂志,2021,32(5):580-581.
[5] 牛翠萍. 阿替普酶溶栓治疗急性脑梗死患者预后的影响因素[J].中国药物与临床,2021,21(6):981-983.
[6] 田金洲,解恒革,秦斌,等.中国血管性轻度认知损害诊断指南[J].中华内科杂志,2016,55(3):249-256.
[7] 张贵臣. 单纯药物治疗与连续采用高压氧联合药物治疗脑神经损伤早期效果的对比研究[J].系统医学,2020,5(12):9-11,23.
[8] Liang F, Sun L, Yang J, et al.The effect of different atmosphere absolute hyperbaric oxygen on the expression of extracellular histones after traumatic brain injury in rats[J].Cell Stress Chaperones,2020,25(6):1013-1024.
[9] Xia A, Huang H, You W, et al.The neuroprotection of hyperbaric oxygen therapy against traumatic brain injury via NF-κB/MAPKs-CXCL1 signaling pathways[J].Exp Brain Res,2022,240(1):207-220.
[10] 邓云苗.高压氧联合药物治疗脑神经损伤早期的临床效果评价[J].中国社区医师,2020,36(7):60,62.
[11] 欧玉姣. 康复护理模式对后组脑神经损伤致吞咽障碍的效果分析[J].黑龙江中医药,2020,49(1):245.
[12] 李修晶,石静云,赵芳萍.神经节苷酯治疗新生儿缺氧缺血性脑病对患者神经相关因子及脑神经损伤程度影响分析[J].中南医学科学杂志,2019,47(4):389-392.
[13] 刘敏,卞玉杰,徐萍欣.复方脑肽节苷脂注射液对重症颅脑损伤患者治疗效果及对预后的影响[J].中国合理用药探索,2019,16(6):142-145,149.
[14] 李微微,顾健.伴脑神经功能缺损的吉兰-巴雷综合征临床特征及相关因素分析[J].中国临床神经科学,2019,27(3):267-272,293.
[15] 秋军峰,郭峥.熄风化痰通络汤配合通督调神针刺法对后循环脑梗死患者脑血流、神经损伤标记物、心率变异性和近期预后的影响[J].现代中西医结合杂志,2019,28(14):1514-1518,1577.
[16] 谢晓娜,林小琼.后组脑神经损伤致吞咽障碍老年患者的康复护理研究[J].中外医学研究,2017,15(35):120-121.
[17] 刘军华. 大分割放疗联合替莫唑胺治疗大体积脑转移瘤的效果观察[J].实用癌症杂志,2017,32(11):1814-1816,1823.